Significant Detection of Circulating Cancer Cells in the Blood by Reverse Transcriptase–Polymerase Chain Reaction During Colorectal Cancer Resection
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 232 (1) , 58-65
- https://doi.org/10.1097/00000658-200007000-00009
Abstract
To analyze the clinical value of reverse transcriptase–polymerase chain reaction (RT-PCR) recognition of mRNA coding for carcinoembryonic antigen (CEA) and cytokeratin 20 in blood obtained from patients with colorectal carcinoma. RT-PCR has been applied to identify very small numbers of tumor cells. Molecular detection is thought to provide useful information for the clinical management of perioperative prophylaxis of tumor cell implantation or postoperative adjuvant therapy regimens. From 52 patients with colorectal cancer, peripheral blood specimens were obtained before and after surgical manipulation; also, a specimen of mesenteric venous blood draining the colorectal tumor was obtained just before tumor resection. Using cDNA primers specific for CEA and cytokeratin 20, RT-PCR was performed to detect tumor cells. Subsequently, the 52 patients were divided into two groups, a group positive for both CEA and cytokeratin 20 and a group negative for CEA, cytokeratin 20, or both. On the basis of 450 days of follow-up data, the PCR-positive group had a significantly shorter overall survival than the PCR-negative group only with the mesenteric venous blood specimens. Multivariate analysis indicated that detection of the simultaneous presence of CEA and cytokeratin 20 mRNA in mesenteric venous blood is a potent prognostic factor independent of the traditional pathologic parameters. Of the eight peripheral blood specimens found to be PCR-positive, five showed a change of PCR from negative to positive during surgery, and liver metastases developed 11 months later in one of these five patients. Molecular detection of both CEA and cytokeratin 20 mRNA in mesenteric venous blood may be of prognostic value for patients with colorectal carcinoma. Molecular detection in the peripheral blood at surgery suggests that hematogenic tumor cell dissemination is a common and early event and that surgical manipulation enhances this release of tumor cells into the circulation.Keywords
This publication has 30 references indexed in Scilit:
- Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after ResectionAnnals of Internal Medicine, 1998
- Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20International Journal of Cancer, 1998
- Detection of K-ras Point Mutations in Mesenteric Venous Blood from Colorectal Cancer Patients by Enriched Polymerase Chain Reaction and Single-strand Conformation Polymorphism AnalysisJapanese Journal of Clinical Oncology, 1996
- Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.Gut, 1996
- The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of diseaseInternational Journal of Cancer, 1996
- Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancerNature Medicine, 1995
- Diagnosis of micrometastases by the amplification of tissue-specific genesGene, 1995
- Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasisJournal of Surgical Research, 1990
- Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.Proceedings of the National Academy of Sciences, 1990
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982